文章名稱引用次數(shù)

• Next generation of immune checkpoint therapy in cancer: new developments and challenges114
• The biology and role of CD44 in cancer progression: therapeutic implications107
• Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications87
• A phase open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma84
• Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy75
• Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel74
• Immune checkpoint inhibitors of PD-L1 as cancer therapeutics72
• Targeting mTOR for cancer therapy64
• Abscopal effect of radiotherapy combined with immune checkpoint inhibitors63
• Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy49